Impel Pharmaceuticals Inc Receivables Turnover Ratio (IMPL), from the third quarter 2023 to the third quarter 2022 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Impel Pharmaceuticals Inc   (NASDAQ: IMPL)
 

Impel Pharmaceuticals Inc Accounts Receivables Turnover Ratio from the third quarter 2023 to the third quarter 2022

Quarterly Results, Trends, Rankings, Statistics


Impel Pharmaceuticals Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2023 to a ratio of 3.03, this represents a new company high. This is a clear indication for improving liquidity at Impel Pharmaceuticals Inc 's clients. Average receivable collection period, for the Impel Pharmaceuticals Inc in Sep 30 2023 quarter, has decreased to 120 days, compared to 129 days, in the Jun 30 2023 quarter.

If we take a look into Healthcare sector 555 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 3596, from overall ranking in the second quarter 2023 at 3702.

What is Receivable Turnover Ratio?
What is Impel Pharmaceuticals Inc Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

IMPL Receivables Turnover Ratio (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter
Y / Y Receivable Change 7.46 % 41.86 % 61.61 % 450.59 % 524.77 %
Y / Y Revenue Change 55.52 % 127.04 % 148.55 % 767.94 % 3286.81 %
Receivable Turnover Ratio (TTM) 3.03 2.83 2.48 2.27 2.03
IMPL's Total Ranking # 3596 # 3702 # 3791 # 4299 # 3874
Accounts Receivable average collection period days 120 129 147 160 179
Seq. Receivable Change -3.16 % 8.3 % -15.64 % 21.46 % 27.85 %
Seq. Revenue Change -24.69 % 45.56 % -12.7 % 62.49 % 9.95 %


Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 195
Healthcare Sector # 556
Overall Market # 3596

Receivable Turnover Ratio Statistics
High Average Low
3.03 2.42 1.9
(Sep 30 2023)   (Jun 30 2022)





IMPL Company Profile • Back to IMPL Efficiency Comparisons • Compare IMPL Receivables Turnover Ratio to its Competitors

Financial Statements
Impel Pharmaceuticals Inc 's Accounts Receivable $ 7 Millions Visit IMPL's Balance sheet
Impel Pharmaceuticals Inc 's Sales TTM $ 21 Millions Visit IMPL's Income Statement
Sources of IMPL's Revenues Visit IMPL's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
IMPL's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
IMPL's Growth Rates IMPL's Roa IMPL's Inventory Turnover Ratio IMPL's Dividend Comparisons
IMPL's Profitability Ratios IMPL's Roi IMPL's Asset Turnover Ratio IMPL's Dividend Growth
IMPL's Valuation Ratios IMPL's Roe IMPL's Financial Strength Ratios IMPL's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2023, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Sep 30 2023 Receivable at quarter ending Sep 30 2023
Zymeworks Inc   8.53 $ 461.579  Millions$ 54.102  Millions
Henry Schein Inc   8.53 $ 12,693.000  Millions$ 1,488.250  Millions
Acadia Healthcare Company Inc   8.49 $ 2,923.743  Millions$ 344.337  Millions
Adma Biologics Inc   8.48 $ 233.238  Millions$ 27.518  Millions
Lensar Inc   8.47 $ 40.291  Millions$ 4.758  Millions
Clearpoint Neuro Inc   8.45 $ 22.319  Millions$ 2.641  Millions
Lumos Pharma Inc   8.39 $ 1.737  Millions$ 0.207  Millions
Silk Road Medical Inc   8.36 $ 169.880  Millions$ 20.317  Millions
Harrow Inc   8.29 $ 114.100  Millions$ 13.772  Millions
Ati Physical Therapy Inc   8.26 $ 678.488  Millions$ 82.158  Millions
Pulmatrix Inc   8.25 $ 6.804  Millions$ 0.824  Millions
AnTix Holdings, Inc.  8.23 $ 1.821  Millions$ 0.221  Millions
Repare Therapeutics Inc   8.21 $ 56.692  Millions$ 6.907  Millions
Radnet Inc   8.19 $ 1,580.122  Millions$ 192.844  Millions
Thermogenesis Holdings Inc   8.19 $ 8.112  Millions$ 0.990  Millions
Lifestance Health Group Inc   8.19 $ 1,004.422  Millions$ 122.691  Millions
Idexx Laboratories Inc  8.15 $ 3,587.375  Millions$ 440.300  Millions
Acadia Pharmaceuticals Inc   8.10 $ 631.886  Millions$ 78.005  Millions
Beone Medicines Ltd   8.08 $ 2,204.465  Millions$ 272.789  Millions
Atricure Inc   8.08 $ 380.309  Millions$ 47.061  Millions
Cerus Corporation  8.07 $ 214.720  Millions$ 26.597  Millions
Cadre Holdings inc   8.05 $ 480.743  Millions$ 59.721  Millions
Ensign Group Inc  8.04 $ 3,558.509  Millions$ 442.690  Millions
Becton Dickinson And Company  8.04 $ 19,372.000  Millions$ 2,410.750  Millions
Veracyte Inc   8.02 $ 343.149  Millions$ 42.793  Millions
Nephros Inc   7.99 $ 12.528  Millions$ 1.567  Millions
Vapotherm Inc   7.98 $ 67.598  Millions$ 8.466  Millions
Aveanna Healthcare Holdings Inc   7.98 $ 1,867.515  Millions$ 234.042  Millions
Insulet Corporation  7.98 $ 1,557.000  Millions$ 195.200  Millions
Glaukos Corp  7.95 $ 303.063  Millions$ 38.126  Millions

Date modified: 2026-08-29T17:43:47+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.